000516 Xi'An International Medical Investment
- 5.76
- +0.09+1.59%
Xi'An International Medical Investment News
International Medicine: Board Audit Committee Annual Report Work Procedure
International Medicine: Revised Comparative Table of the Rules of Work of the Executive Committee
International Medicine: 2024 Semi-Annual Financial Report
International Medicine: Revised Comparative Table of “Rules of Work for Board Secretaries”
International Medicine: Revised Comparative Table of “Working Rules for Annual Reports of the Board of Directors and Audit Committee”
International Medicine: Rules of Work for Board Secretaries
International Medicine: Half-year summary table of non-operating capital usage and other related capital transactions
International Medicine: Executive Committee Rules of Work
Xi'An International Medical Investment: 2023 Annual General Meeting of Shareholders Legal Opinions
Xi'An International Medical Investment: Board of Directors Rules of Procedure
Xi'An International Medical Investment: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Xi'An International Medical Investment: Announcement on the repurchase and cancellation of some restricted shares, reduction in registered capital and notification to creditors
Xi'An International Medical Investment: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Xi'An International Medical Investment: Rules of work of special committees of the board of directors
Xi'An International Medical Investment: Internal Control Self-Assessment Report
Xi'An International Medical Investment: Announcement on the repurchase and cancellation of some restricted shares, reduction in registered capital and notification to creditors
Xi'An International Medical Investment: Independent directors' annual report work system
Xi'An International Medical Investment: Notice of Annual General Meeting of Shareholders
International Medicine: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
International Medicine: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Analysis
Price Target
No Data
No Data